1-3 of 3
Gang Yang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Golcadomide (GOLCA), a potential, first-in-class, oral CELMoD™ agent, ± rituximab (R) in patients with Relapsed/Refractory follicular lymphoma (R/R FL): Phase 1/2 study extended follow-up Results

Free
Julio Chavez, Jason Westin, Javier Munoz, Emmanuel Bachy, Judit Jørgensen, Guilherme Perini, Daniel Morillo, Abel Costa, Parth Rao, Berengere De Moucheron, Gang Yang, Soraya Carrancio, Akshay Sudhindra, Michael Pourdehnad, Jessica Voetsch, Serena Perna, Jean-Marie Michot
Journal: Blood
Blood (2025) 146 (Supplement 1): 1006.
https://doi.org/10.1182/blood-2025-1006
Published: 2025
Journal Articles

Golcadomide (GOLCA), a potential, first-in-class, oral CELMoD™ agent, ± rituximab (R) in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Phase 1/2 study extended follow-up Results

Free
Marc Hoffmann, Julio Chavez, Jason Westin, Judit Jørgensen, Javier Munoz, Cecilia Carpio, Guilherme Perini, Emmanuel Bachy, Victoria Campbell, Caroline Hasselbalch Riley, Franck Morschhauser, Daniel Morillo, Alev Akyol, Berengere De Moucheron, Michael Pourdehnad, Akshay Sudhindra, Soraya Carrancio, Jessica Voetsch, Gang Yang, Serena Perna, Jean-Marie Michot
Journal: Blood
Blood (2025) 146 (Supplement 1): 479.
https://doi.org/10.1182/blood-2025-479
Published: 2025
Journal Articles

The control of hematopoietic stem cell maintenance, self-renewal, and differentiation by Mysm1-mediated epigenetic regulation

Free
Tao Wang, Vijayalakshmi Nandakumar, Xiao-Xia Jiang, Lindsey Jones, An-Gang Yang, Xue F. Huang, Si-Yi Chen
Journal: Blood
Blood (2013) 122 (16): 2812–2822.
https://doi.org/10.1182/blood-2013-03-489641
Published: 2013
Includes: Supplemental data